Qualigen Therapeutics Net Income
| QLGNDelisted Stock | USD 2.33 0.00 0.00% |
As of the 10th of February, Qualigen Therapeutics holds the Risk Adjusted Performance of (0.07), variance of 39.48, and Coefficient Of Variation of (1,042). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Qualigen Therapeutics, as well as the relationship between them.
Qualigen Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Qualigen Therapeutics' valuation are provided below:Qualigen Therapeutics does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Qualigen |
Search Suggestions
| QL | QL RESOURCES | CompanyDelisted |
| QLYS | Qualys Inc | Company |
| QLFNX | Aqr Lse Fusion | Mutual Fund |
| QLD | ProShares Ultra QQQ | ETF |
| QLC | QLC | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Qualigen Therapeutics reported net income of (6.36 Million). This is 101.86% lower than that of the Biotechnology sector and 109.08% lower than that of the Health Care industry. The net income for all United States stocks is 101.11% higher than that of the company.
Qualigen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Qualigen Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Qualigen Therapeutics could also be used in its relative valuation, which is a method of valuing Qualigen Therapeutics by comparing valuation metrics of similar companies.Qualigen Therapeutics is currently under evaluation in net income category among its peers.
Qualigen Fundamentals
| Return On Equity | -8.42 | |||
| Return On Asset | -1.72 | |||
| Current Valuation | 12.26 M | |||
| Shares Outstanding | 2.03 M | |||
| Shares Owned By Insiders | 1.79 % | |||
| Shares Owned By Institutions | 1.61 % | |||
| Number Of Shares Shorted | 382.95 K | |||
| Price To Book | 0.41 X | |||
| Price To Sales | 0.39 X | |||
| Gross Profit | 1.04 M | |||
| EBITDA | (5.24 M) | |||
| Net Income | (6.36 M) | |||
| Cash And Equivalents | 6.62 M | |||
| Cash Per Share | 1.57 X | |||
| Total Debt | 2.01 M | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 2.13 X | |||
| Book Value Per Share | (4.12) X | |||
| Cash Flow From Operations | (6.33 M) | |||
| Short Ratio | 0.12 X | |||
| Earnings Per Share | 6.32 X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 11 | |||
| Beta | 0.28 | |||
| Market Capitalization | 6.53 M | |||
| Total Asset | 4.69 M | |||
| Retained Earnings | (123.06 M) | |||
| Working Capital | 2.68 M | |||
| Net Asset | 4.69 M |
About Qualigen Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Qualigen Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qualigen Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qualigen Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Qualigen Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qualigen Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Qualigen Stock
Moving against Qualigen Stock
| 0.82 | GPOVF | Grupo Carso SAB | PairCorr |
| 0.79 | MRK | Merck Company | PairCorr |
| 0.66 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.65 | WMT | Walmart Common Stock | PairCorr |
| 0.61 | AA | Alcoa Corp | PairCorr |
The ability to find closely correlated positions to Qualigen Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qualigen Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qualigen Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qualigen Therapeutics to buy it.
The correlation of Qualigen Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qualigen Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qualigen Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qualigen Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Qualigen Stock
If you are still planning to invest in Qualigen Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qualigen Therapeutics' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |